A group of investigators led by Shuming Nie.

Artificial antibody delivers nanoparticles to tumors Antibodies that focus on epidermal growth factor receptor have proven themselves while potent anticancer drugs. Right now, a group of investigators led by Shuming Nie, Ph.D cialis-suisse.net here ., and Lily Yang, Ph.D., both at the Emory University School of Medicine and associates of the Emory-Georgia Tech Nanotechnology Center for Individualized and Predictive Oncology, is certainly aiming to capitalize upon this targeting ability, utilizing a modified anti-EGFR antibody to delivery nanoparticles into tumor cells. Reporting its work in the journal Small, the Emory team describes its usage of a so-known as single-chain antibody to mimic the tumor-targeting properties of a standard anti-EGFR antibody.

Other entries from category "beauty":

Random entries